Ciprofloxacin extended release - Bayer
At a glance
- Drug Originator Ranbaxy Laboratories
- Drug Licenced by Bayer; Merck & Co
- Drug Class Anti-infectives; Antibacterials; Carboxylic acids; Cyclopropanes; Fluoroquinolones; Piperazines; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
- USA Patent Applicants BAYER HLTHCARE
- USA Patents 3
- NDAs 1
- Patent Applications 4,455
Table of Contents

Disclaimer